Conning Inc. Sanofi Transaction History

Conning Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 21, 2023	SELL	$50.45 - $57.18 $7,416 - $8,405	-147 Reduced 3.24%	4,389 $236,000
Q4 2022 Feb 07, 2023	BUY	$38.86 - $48.55 $176,268 - $220,222	4,536 New	4,536 $219,000
Q2 2022 Jul 20, 2022	SELL	$48.99 - $57.46 $75,787 - $88,890	-1,547 Reduced 23.96%	4,909 $246,000
Q3 2021 Nov 05, 2021	BUY	$47.89 - $53.12 $309,177 - $342,942	6,456 New	6,456 $311,000
Q2 2020 Aug 07, 2020	SELL	$42.91 - $52.5 $498,142 - $609,472	-11,609 Closed	0 $0
Q1 2020 Apr 29, 2020	SELL	$38.02 - $51.66 $75,165 - $102,131	-1,977 Reduced 14.55%	11,609 $508,000
Q4 2019 Jan 29, 2020	SELL	$44.25 - $50.86 $121,864 - $140,068	-2,754 Reduced 16.85%	13,586 $682,000
Q3 2019 Oct 30, 2019	BUY	$40.34 - $46.64 $110,491 - $127,746	2,739 Added 20.14%	16,340 $757,000
Q2 2019 Jul 25, 2019	BUY	$40.43 - $44.3 $25,107 - $27,510	621 Added 4.78%	13,601 $589,000
Q1 2019 Apr 22, 2019	SELL	$40.83 - $45.43 $79,373 - $88,315	-1,944 Reduced 13.03%	12,980 $575,000
Q4 2018 Jan 29, 2019	BUY	$41.48 - $45.59 $229,135 - $251,839	5,524 Added 58.77%	14,924 $648,000
Q3 2018 Oct 26, 2018	SELL	$40.0 - $44.84 $82,000 - $91,922	-2,050 Reduced 17.9%	9,400 $420,000
Q2 2018 Jul 25, 2018	SELL	$37.63 - $41.22 $14,449 - $15,828	-384 Reduced 3.24%	11,450 $458,000
Q1 2018 May 04, 2018	BUY	$38.98 - $45.76 $48,101 - $56,467	1,234 Added 11.64%	11,834 $474,000
Q4 2017 Jan 30, 2018	SELL	$42.86 - $50.61 $38,574 - $45,549	-900 Reduced 7.83%	10,600 $456,000
Q3 2017 Oct 20, 2017	BUY	$47.04 - $50.34 $540,960 - $578,910	11,500	11,500 $573,000

810

267M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $136B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

Stay updated on Conning Inc. with notifications on news.